317 related articles for article (PubMed ID: 29273043)
1. Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma.
Bharmal M; Fofana F; Barbosa CD; Williams P; Mahnke L; Marrel A; Schlichting M
Health Qual Life Outcomes; 2017 Dec; 15(1):247. PubMed ID: 29273043
[TBL] [Abstract][Full Text] [Related]
2. Update on the psychometric properties and minimal important difference (MID) thresholds of the FACT-M questionnaire for use in treatment-naïve and previously treated patients with metastatic Merkel cell carcinoma.
Bharmal M; Nolte S; Henry-Szatkowski M; Hennessy M; Schlichting M
Health Qual Life Outcomes; 2020 May; 18(1):145. PubMed ID: 32430019
[TBL] [Abstract][Full Text] [Related]
3. Psychometric Properties of EQ-5D-5L Scoring Algorithms for the United Kingdom in Metastatic Merkel Cell Carcinoma.
Bharmal M; Hunger M; Schlichting M
Value Health; 2019 Oct; 22(10):1170-1177. PubMed ID: 31563260
[TBL] [Abstract][Full Text] [Related]
4. Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients.
Degboe A; Ivanescu C; Rohay JM; Turner RR; Cella D
Support Care Cancer; 2019 Nov; 27(11):4189-4198. PubMed ID: 30825026
[TBL] [Abstract][Full Text] [Related]
5. Nonprogression with avelumab treatment associated with gains in quality of life in metastatic Merkel cell carcinoma.
Kaufman HL; Hunger M; Hennessy M; Schlichting M; Bharmal M
Future Oncol; 2018 Feb; 14(3):255-266. PubMed ID: 29219612
[TBL] [Abstract][Full Text] [Related]
6. Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis.
Salaffi F; Malavolta N; Cimmino MA; Di Matteo L; Scendoni P; Carotti M; Stancati A; Mulé R; Frigato M; Gutierrez M; Grassi W;
Clin Exp Rheumatol; 2007; 25(3):390-403. PubMed ID: 17631735
[TBL] [Abstract][Full Text] [Related]
7. Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease.
Finkelstein FO; van Nooten F; Wiklund I; Trundell D; Cella D
Health Qual Life Outcomes; 2018 May; 16(1):111. PubMed ID: 29855366
[TBL] [Abstract][Full Text] [Related]
8. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
[TBL] [Abstract][Full Text] [Related]
9. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire.
Coyne KS; Soliman AM; Margolis MK; Thompson CL; Chwalisz K
Curr Med Res Opin; 2017 Feb; 33(2):193-200. PubMed ID: 27733082
[TBL] [Abstract][Full Text] [Related]
10. Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinical Trial.
Lambert J; Marrel A; D'Angelo SP; Burgess MA; Chmielowski B; Fazio N; Gambichler T; Grob JJ; Lebbé C; Robert C; Russell J; Güzel G; Bharmal M
Patient; 2020 Aug; 13(4):457-467. PubMed ID: 32472503
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the psychometric properties of the Short-Form Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) following surgical placement of Prolift+M: a transvaginal partially absorbable mesh system for the treatment of pelvic organ prolapse.
Roy S; Mohandas A; Coyne K; Gelhorn H; Gauld J; Sikirica V; Milani AL
J Sex Med; 2012 Apr; 9(4):1190-9. PubMed ID: 22353162
[TBL] [Abstract][Full Text] [Related]
12. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF).
Gelhorn HL; Roberts LJ; Khandelwal N; Revicki DA; DeRogatis LR; Dobs A; Hepp Z; Miller MG
J Sex Med; 2017 Aug; 14(8):1046-1058. PubMed ID: 28760247
[TBL] [Abstract][Full Text] [Related]
13. Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort's QuAliV ancillary study.
Barger D; Hessamfar M; Neau D; Vareil MO; Lazaro E; Duffau P; Rouanes N; Leleux O; Le Marec F; Erramouspe M; Wittkop L; Dabis F; Bonnet F
Health Qual Life Outcomes; 2020 Jul; 18(1):220. PubMed ID: 32650781
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial.
Viala-Danten M; Martin S; Guillemin I; Hays RD
Health Qual Life Outcomes; 2008 Dec; 6():113. PubMed ID: 19091084
[TBL] [Abstract][Full Text] [Related]
15. Validation of the functional assessment of cancer therapy-gastric module for the Chinese population.
Zhou HJ; So JB; Yong WP; Luo N; Zhu F; Naidoo N; Li SC; Yeoh KG
Health Qual Life Outcomes; 2012 Nov; 10():145. PubMed ID: 23194009
[TBL] [Abstract][Full Text] [Related]
16. Psychometric properties of the quality of life in short statured youth (QoLISSY) questionnaire within the course of growth hormone treatment.
Bloemeke J; Silva N; Bullinger M; Witt S; Dörr HG; Quitmann J
Health Qual Life Outcomes; 2019 Mar; 17(1):49. PubMed ID: 30885197
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
Grob JJ; Amonkar MM; Karaszewska B; Schachter J; Dummer R; Mackiewicz A; Stroyakovskiy D; Drucis K; Grange F; Chiarion-Sileni V; Rutkowski P; Lichinitser M; Levchenko E; Wolter P; Hauschild A; Long GV; Nathan P; Ribas A; Flaherty K; Sun P; Legos JJ; McDowell DO; Mookerjee B; Schadendorf D; Robert C
Lancet Oncol; 2015 Oct; 16(13):1389-98. PubMed ID: 26433819
[TBL] [Abstract][Full Text] [Related]
18. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
19. Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness.
Bilbao A; García-Pérez L; Arenaza JC; García I; Ariza-Cardiel G; Trujillo-Martín E; Forjaz MJ; Martín-Fernández J
Qual Life Res; 2018 Nov; 27(11):2897-2908. PubMed ID: 29978346
[TBL] [Abstract][Full Text] [Related]
20. Living with Merkel Cell Carcinoma (MCC): Development of a Conceptual Model of MCC Based on Patient Experiences.
Kaufman HL; Dias Barbosa C; Guillemin I; Lambert J; Mahnke L; Bharmal M
Patient; 2018 Aug; 11(4):439-449. PubMed ID: 29512061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
